GlassScriptPhysician profile
Sool Kee Song
NPI 1891177382
$23,157.58
in general payments reported to CMS, 2019-2025
57 companies · $2,346 in 2025
The $2,346 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,223 · 2020: $3,271 · 2021: $4,250 · 2022: $3,624 · 2023: $3,118 · 2024: $2,325 · 2025: $2,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,729 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,728.50 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,894.65 | 2019-2025 | Evenity, Prolia, Otezla |
| Abbvie INC. | $2,886.21 | 2019-2025 | Vraylar, Linzess, Ubrelvy |
| Amarin Pharma, INC. | $1,698.18 | 2019-2023 | |
| Radius Health, INC. | $1,503.66 | 2019-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $1,372.75 | 2019-2023 | |
| Novo Nordisk INC | $1,356.25 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,176.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $1,147.81 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $718.69 | 2020-2023 | |
| Gilead Sciences, INC. | $702.71 | 2019-2025 | Vemlidy |
| Bayer Healthcare Pharmaceuticals INC. | $601.18 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $587.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $524.36 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $513.37 | 2019-2025 | Gardasil 9, Capvaxive |
| Astellas Pharma US INC | $466.07 | 2019-2025 | Veozah, Myrbetriq |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $461.69 | 2019-2025 | Kisunla |
| Aimmune Therapeutics, INC. | $397.38 | 2024-2025 | Zenpep |
| Ardelyx, INC. | $373.66 | 2023-2025 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.95 | 2019-2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $315.08 | 2024-2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $290.09 | 2019-2025 | Zoryve, Livalo |
| Scilex Pharmaceuticals INC. | $274.03 | 2020-2024 | Ztlido |
| Esperion Therapeutics, INC. | $180.46 | 2021-2025 | Nexletol |
| Allergan, INC. | $177.93 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $177.28 | 2023-2025 | Gemtesa |
| Dexcom, INC. | $145.20 | 2022-2025 | Dexcom G6 Transmitter |
| Vivus LLC | $135.84 | 2021-2022 | |
| Exact Sciences Corporation | $129.79 | 2023-2025 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $128.53 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $121.84 | 2025 | Voquezna |
| Ibsa Pharma INC. | $106.79 | 2022-2025 | Tirosint, Licart, Tirosint |
| Novartis Pharmaceuticals Corporation | $106.70 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $106.32 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $105.60 | 2020-2024 | Strensiq |
| Glaxosmithkline, LLC. | $102.92 | 2019-2024 | Shingrix, Arexvy |
| Biohaven Pharmaceuticals, INC. | $85.01 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $80.93 | 2024-2025 | Rexulti |
| Corcept Therapeutics | $64.01 | 2022-2023 | Korlym |
| Vbi Vaccine (Delaware) INC. | $59.35 | 2023 | Prehevbrio |
| Corium, LLC | $56.13 | 2023 | Adlarity |
| Alk-Abello, INC | $52.83 | 2025 | Grastek, Ragwitek, Odactra |
| Horizon Therapeutics Plc | $47.68 | 2022 | |
| Paratek Pharmaceuticals, INC. | $44.46 | 2020 | |
| Boston Scientific Corporation | $41.23 | 2025 | Wavewriter Alpha Prime 16 |
| Xeris Pharmaceuticals, INC. | $38.45 | 2023 | Gvoke Hypopen |
| Azurity Pharmaceuticals, INC. | $32.70 | 2023 | Horizant |
| Genentech USA, INC. | $31.41 | 2019-2021 | |
| Almatica Pharma LLC | $25.04 | 2021 | |
| Lundbeck LLC | $22.86 | 2022 | |
| Medtronic, INC. | $21.14 | 2024 | Intellis Adaptivestim |
| Vital Connect, INC | $20.99 | 2025 | Vitalpatch Rtm |
| Sanofi Pasteur INC. | $20.86 | 2022 | |
| Echosens North America, INC. | $20.01 | 2025 | Fibroscan |
| Tempus Ai, INC | $19.85 | 2024 | |
| Philips North America LLC | $16.63 | 2024 | (Ck7) Extended Holter |
| Hologic Sales and Service, LLC | $12.90 | 2021 | |
| Currax Pharmaceuticals LLC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sool Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.